In the last decade, the role of CROs has become increasingly integral to clinical trials, with smaller companies often outsourcing the vast majority of their services to these firms. However the growing need for CRO services has placed demand on these companies, many of whom are cracking under the pressure.  Additionally, post-Covid staffing issues have wreaked havoc with CROs with many of them understaffed or having under qualified personnel fill roles that are not suited to them. In the past few years, we have seen the impact of over-promising and under-staffed CROs who are consistently under-delivering on their promises. From delays in deliverables to larger quality concerns, the realization that CROs are less dependable is starting to permeate through the industry, forcing companies to look towards other solutions.

In addition to the above, with the FDAs increased emphasis on vendor oversight and management, companies cannot afford to partner with vendors who are not holding up their fulfilling their contractual commitments and prove to be a challenge to work with.

One of the primary solutions to these CRO-issues: bringing more functionality in-house.

In lieu of signing up with one CRO to outsource the vast majority of clinical trial functions, companies are adopting a hybrid approach to vendor selection.  Some companies are now shopping “a la carte” for services opting to get support in some areas but taking other aspects in-house.

With this new impetus to bring increased functionality in-house, comes the new need for support in setting up and maintaining that internal infrastructure.

That is where a partner like MVG Consulting comes into play. With a hands-on, outcome-focused approach, MVG offers flexible a-la carte services based directly on client needs that allows clients to confidently transition some of their functions in-house.

If you’ve been on the receiving end of some of these industry difficulties and are in need of effective partnership for your clinical programs, MVG is the perfect place to start. Contact our team at MVG to discuss how we can help support your clinical program.

MVG Consulting Services specializes in helping small to medium sized biotechnology and pharmaceutical companies with their clinical development programs and we can provide start-up and virtual companies with the necessary resources to begin their clinical development program.

Services include:

  • Clinical Research Consulting Services
  • Clinical Trial Development
  • Project Rescue
  • Inspection Readiness

MVG provides highly qualified clinical research professionals who seamlessly become a part of your project team. Additionally, we provide virtual companies with an entire project team that encompasses all aspects of clinical development.

We invite you to fill out the form below to learn more about how MVG Consulting can help you with your clinical devleopment needs.

Pin It on Pinterest